Quantamental Technologies LLC Madrigal Pharmaceuticals, Inc. Transaction History

Quantamental Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$58.39 - $296.54 $52,083 - $264,513	892 New	892 $258,000
Q4 2019 Feb 14, 2020	SELL	$84.28 - $118.5 $1,517 - $2,133	-18 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$84.4 - $106.53 $66,929 - $84,478	-793 Reduced 97.78%	18 $2,000
Q2 2019 Aug 12, 2019	SELL	$91.13 - $142.5 $7,472 - $11,685	-82 Reduced 9.18%	811 $85,000
Q1 2019 Apr 29, 2019	BUY	$103.48 - $143.84 $9,623 - $13,377	93 Added 11.63%	893 $112,000
Q4 2018 Jan 28, 2019	BUY	$94.77 - $215.54 $75,816 - $172,432	800 New	800 $90,000

335

22.3M

960K

940K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.75B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.